Simplify Logo

Full-Time

District Sales Manager

Detroit

Posted on 7/3/2024

HeartFlow

HeartFlow

501-1,000 employees

Non-invasive cardiac testing for heart disease

Data & Analytics
Hardware
AI & Machine Learning
Biotechnology
Healthcare

Compensation Overview

$150k - $300kAnnually

+ Stock Options

Expert

Remote in USA

Category
Strategic Account Management
Sales & Account Management
Required Skills
Sales
Communications
Salesforce
Customer Service
Requirements
  • History of proven sales skills and sales achievements
  • Experience in sales within Cardiology (radiology experience is a plus)
  • Knowledge/experience developing and implementing go-to-market plans for new diagnostic or therapeutic area
  • Deep understanding of cardiovascular disease and relationships with practitioners in the assigned region
  • Strong problem-solving skills
  • Knowledge/experience in physician education regarding new technologies
  • Knowledge/experience creating tactical sales plans for segmentation and anticipated adoption of HeartFlow technologies
  • Self-starter with high initiative
  • A pattern of winning/driving revenue
  • Technical aptitude; able to discuss/explain a complex technology
  • Experience with Salesforce.com or similar CRM
  • Excellent teamwork and communication skills; ability to work in a fast-paced adaptive environment
  • BA Degree
  • 10+ years of healthcare and/or business-to-business sales experience in a cardio/cardiovascular environment. Medical device sales experience required
Responsibilities
  • Drive sales of HeartFlow’s technology at new accounts
  • Drive penetration of HeartFlow’s technology within existing accounts
  • Achieve sales goals in the assigned geography
  • Collaborate with the commercial team to develop detailed plans/strategies for HeartFlow adoption and penetration
  • Coordinate priorities/activities of a team to drive sales, increase adoption, and deliver excellent customer service
  • Gather 'voice of customer' input to guide product development and market strategy
  • Utilize salesforce.com to manage all facets of business

HeartFlow provides a non-invasive cardiac test that helps visualize a patient's coronary arteries in detail. This technology allows physicians to diagnose and treat heart disease more effectively without the need for invasive procedures, which reduces risks for patients and costs for healthcare providers. HeartFlow's main clients are healthcare professionals seeking safer diagnostic methods. The company's product offerings include the HeartFlow Analysis, which consists of various analyses like FFRCT, RoadMap, and Plaque Analysis, all of which have received FDA clearance and are available in multiple countries including the US, UK, Japan, and Canada. Unlike competitors, HeartFlow focuses on non-invasive solutions that enhance treatment planning and patient safety. The goal of HeartFlow is to improve cardiovascular care by providing advanced diagnostic tools that facilitate better treatment decisions.

Company Stage

Series F

Total Funding

$1.2B

Headquarters

Redwood City, California

Founded

2010

Growth & Insights
Headcount

6 month growth

6%

1 year growth

13%

2 year growth

17%
Simplify Jobs

Simplify's Take

What believers are saying

  • The recent $215 million Series F funding round led by Bain Capital Life Sciences positions HeartFlow for significant growth and expansion.
  • HeartFlow's AI-enabled products, such as the RoadMap Analysis, enhance diagnostic accuracy and efficiency, potentially improving patient outcomes and physician workflows.
  • With coverage by 100% of Medicare and over 98% of commercial payers, HeartFlow's technology is widely accessible, increasing its adoption and market penetration.

What critics are saying

  • The cardiovascular care market is highly competitive, requiring continuous innovation to maintain a leading position.
  • Regulatory hurdles and the need for ongoing FDA clearances could delay product launches and market entry.

What makes HeartFlow unique

  • HeartFlow's non-invasive cardiac test offers a safer and more efficient alternative to traditional invasive procedures, setting it apart in the cardiovascular care market.
  • The company's comprehensive product portfolio, including FFRCT, RoadMap, and Plaque Analysis, provides a unique combination of anatomical and physiological visualization of coronary arteries.
  • HeartFlow's technology has received FDA clearance and is commercially available in multiple countries, ensuring a broad market reach and regulatory credibility.
INACTIVE